Sha Zhou, Chang Kejie, Mi Jiaoping, Liang Zibin, Hu Liyang, Long Fengjiao, Shi Haiyan, Lin Zhong, Wang Xiaojin, Pei Xiaofeng
Department of Thoracic Oncology, Cancer Center of the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China.
Department of Otorhinolaryngology of the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China.
Ann Palliat Med. 2020 Sep;9(5):3373-3378. doi: 10.21037/apm-20-1662.
The coronavirus disease (COVID-19) poses an unprecedented challenge to health and epidemic prevention system, especially the healthcare of patients with cancer. We sought to study the impact of COVID-19 on lung cancer patients in our center.
We initiated a retrospectively study to analyze the impact of COVID-19 on lung cancer patients in our center, who were accepted for routine anticancer treatment before the epidemic and planned to return to hospital in January and February of 2020.
A total of 161 cases of lung cancer were included in the final analysis. As of April 15, 95 patients had delayed their return visit, and 47 cases were finally designated as having delayed admission during the epidemic and having to discontinue or delay their regular anticancer treatments. Of these 47 delayed patients, 33 were evaluated for tumor status using a computed tomography scan, 6 of these 33 cases (18.18%) were diagnosed as progressive disease (PD), and 5 cases did not return for visit.
This is the first study investigating impact of COVID-19 on non-COVID-19 lung cancer patients during the pandemic. The study demonstrates the significant impact of the COVID-19 crisis on oncological care, indicating the need for appropriate change of treatment decisions and continued follow-up and psycho-oncological support during this pandemic.
冠状病毒病（COVID-19）对卫生和防疫系统构成了前所未有的挑战，尤其是对癌症患者的医疗护理。我们试图研究COVID-19对我们中心肺癌患者的影响。
我们开展了一项回顾性研究，以分析COVID-19对我们中心肺癌患者的影响，这些患者在疫情爆发前接受常规抗癌治疗，并计划于2020年1月和2月返回医院。
最终分析共纳入161例肺癌患者。截至4月15日，95例患者推迟了复诊，47例最终被确定为在疫情期间延迟入院，不得不中断或推迟其常规抗癌治疗。在这47例延迟患者中，33例通过计算机断层扫描评估了肿瘤状态，这33例中的6例（18.18%）被诊断为疾病进展（PD），5例未复诊。
这是第一项调查COVID-19大流行期间对非COVID-19肺癌患者影响的研究。该研究证明了COVID-19危机对肿瘤护理的重大影响，表明在此大流行期间需要适当改变治疗决策，并持续进行随访和心理肿瘤学支持。
